comparemela.com

Latest Breaking News On - Jewish communal fund - Page 15 : comparemela.com

Jewish Communal Fund Adds New Jewish Values Impact Investments to its Platform

Jewish Communal Fund Adds New Jewish Values Impact Investments to its Platform The addition of JLens and Ogen offers JCF Fundholders the ability to choose social impact investments that reflect their values and align with their grant-making News provided by Share this article Share this article NEW YORK, March 9, 2021 /PRNewswire/  Jewish Communal Fund has added new Jewish values impact investments that align with its mission as the largest Jewishly-affiliated donor advised fund in the country. These offerings provide JCF Fundholders with the opportunity to maximize their impact with their investments, in addition to their active grant-making. These new investments complement the ESG and socially responsible investment options already on JCF s robust investment platform.

In a bad economy, some Jewish giving is up—way up

The economy is at a standstill, people are out of work and stuck home and big Israel-support organizations are having a banner year. The Jewish National Fund raised a record $100.8 million last year in the United States, even as the pandemic canceled live fundraising events and JNF-sponsored trips to Israel. Courtesy of Facebook Finance Ministry Accountant General, Yali Rothenberg, addressing global Israel Bonds leadership and staff February 9 via Zoom. At the same time, State of Israel Bonds also set a record of $1.8 billion in sales worldwide last year $1.5 billion in sales in the U.S. alone, an increase of $400 million over its original goal.

Revealed: Israeli Settler Groups With Ties To the US Are Evicting Palestinians in Mass

Comments Occupied East Jerusalem Nearly 20 Palestinian families face homelessness amid a raging pandemic and cold, wet winter in occupied East Jerusalem because of eviction lawsuits from Israeli settler groups backed by wealthy American donors. Over the last few months, Israeli courts upheld the eviction orders of 16 Palestinian families in the East Jerusalem districts of Silwan and Sheikh Jarrah. The evictions are carried out through lawsuits by Israeli company Nachalat Shimon and settler associations Ateret Cohanim and Elad. These three organizations argue the land the families’ homes are on belongs to them because Yemeni Jews owned the land before 1948. Israel’s discriminatory Legal and Administrative Matters Law allows Jews to claim ownership of property they lost during the 1948 War but doesn’t guarantee that same right to Palestinians.

Jewish Communal Fund Fundholders Granted $536 Million in FY 20; Grant-making Increased by 18%

The 2020 JCF Giving Report highlights the extraordinary generosity of our Fundholders, who increased their giving in the wake of the pandemic and continue to provide additional support to meet increased needs, said Sue Dickman, the Executive Vice President & CEO of Jewish Communal Fund. One of the longest-serving donor advised funds in the country, JCF is now facilitating charitable giving for many third-generation JCF Fundholders showcasing the passion for philanthropy that they learned from their parents and grandparents before them. Now entering its 49th year, JCF plays a critical role in facilitating charitable giving for a wide spectrum of Jewish philanthropists of varying means, ages, interests and religious affiliations.

Recurrent GBM brain tumors with few mutations respond best to immunotherapy

 E-Mail DURHAM, N.C. - Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they ve grown back, enabling up to 20% of patients to live well beyond predicted survival times. What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives. New insights from a team led by Duke s Preston Robert Tisch Brain Tumor Center provide potential answers. The team found that recurring glioblastoma tumors with very few mutations are far more vulnerable to immunotherapies than similar tumors with an abundance of mutations. The finding, appearing online Jan. 13 in the journal

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.